Innovation.
It means being creative with what a product can be.
Exploring more. Asking bigger questions.
Thinking a bit differently. So the resulting product profile is the right product profile, not just the first thought.
FIVE-X is the new standard for path to market options. It’s a way of working that ensures teams stay curious throughout the process to keep alternatives alive.
Fastest path to market
Fastest isn’t always best, but it should always be an option. At any given time, what is the fastest route to market?
Index Patient = Precision
Precision medicine. Also known as the perfect patient approach. If you only got paid if the drug worked, which path would you choose?
Value at any time
You’ve explored fastest. Now consider the lowest cost path to market at any given time.
Expected Pathways
Whilst you may not go down your expected route with us, it's always useful to know what it is. What is the default path to market?
Unexpected pathways
Think a bit differently. Pursue the path least trodden to conjure up something no one would ever expect.
FIVE-X is distilled from 10 years of insights into pharmaceutical innovation, delivering asymmetric advantage and meaningfully different path to market choices. It allows you to assess the risks and rewards of each. To explore possibility and probability.
Only then can you make a truly informed decision on the best possible path. With FIVE-X, you gain advantage from your decision making not just your product.
We see it differently
Design thinking, and design doing. With a sweet spot at the beginning of phase II.
We’re focused on understanding possibility and maximising probability of success.
We understand what your molecule could be and what the market might want.
